SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001587221-22-000022
Filing Date
2022-03-17
Accepted
2022-03-17 16:09:26
Documents
92
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zsan-20211231.htm   iXBRL 10-K 2159447
2 EX-10.40 exhibit1040-patheonamendme.htm EX-10.40 35220
3 EX-10.41 exhibit1041-performanceopt.htm EX-10.41 27788
4 EX-10.42 exhibit1042-psuagreement.htm EX-10.42 66989
5 EX-10.43 exhibit1043-trinityseconda.htm EX-10.43 40447
6 EX-23.1 exhibit231deloittefy2110k.htm EX-23.1 2296
7 EX-31.1 exhibit311fy2110k.htm EX-31.1 9203
8 EX-31.2 exhibit312fy2110k.htm EX-31.2 9208
9 EX-32.1 exhibit321fy2110k.htm EX-32.1 7981
15 GRAPHIC image_0.jpg GRAPHIC 272
16 GRAPHIC image_2.jpg GRAPHIC 153
17 GRAPHIC image_3.jpg GRAPHIC 162
18 GRAPHIC image_4.jpg GRAPHIC 145
19 GRAPHIC zsan-20211231_g1.jpg GRAPHIC 85134
20 GRAPHIC zsan-20211231_g2.jpg GRAPHIC 105634
21 GRAPHIC zsan-20211231_g3.jpg GRAPHIC 98198
  Complete submission text file 0001587221-22-000022.txt   9680607

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20211231.xsd EX-101.SCH 70267
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20211231_cal.xml EX-101.CAL 86026
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20211231_def.xml EX-101.DEF 344785
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20211231_lab.xml EX-101.LAB 761726
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20211231_pre.xml EX-101.PRE 512874
86 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20211231_htm.xml XML 1249758
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36570 | Film No.: 22748583
SIC: 2834 Pharmaceutical Preparations